PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor.

被引：0
|
作者：
Ding, Liya [1 ]
Wang, Qiwei [1 ]
Kearns, Michael [1 ]
Jiang, Tao [1 ]
Konstantinopoulos, Panagiotis [1 ]
Matulonis, Ursula [1 ]
Zhao, Jean [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA17
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [31] Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling
    Wei, Yousheng
    Ou, Tingyu
    Lu, Yan
    Wu, Guangteng
    Long, Ying
    Pan, Xinbin
    Yao, Desheng
    PEERJ, 2020, 8
  • [32] The Apelin/APLNR system modulates tumor immune response by reshaping the tumor microenvironment
    Yang, Yuqin
    Chen, Meilin
    Qiu, Yanbing
    Li, Xiaoxu
    Huang, Yumei
    Zhang, Wenling
    Dodurga, Yavuz
    GENE, 2022, 834
  • [33] 53BP1 loss mediated PARP inhibitor resistance in BRCA1-deficient pancreatic cancer is overcome with immune checkpoint blockade
    Patterson-Fortin, Jeffrey
    Sun, Yajie
    Han, Sen
    Li, Zhe
    Nowicka, Zuzanna
    Hirohashi, Yuna
    Kilgas, Susan
    Yi, Jae Kyo
    Spektor, Alexander
    Fendler, Wojciech
    Konstantinopoulos, Panagiotis
    D'Andrea, Alan D.
    Chowdhury, Dipanjan
    CANCER RESEARCH, 2024, 84 (01)
  • [34] The effect of PARP inhibition on BAX/BAK independent synthetic lethality of BRCA1-deficient non-small cell lung cancer
    Paul, I.
    Savage, K.
    Lamers, E.
    Gately, K.
    O'Byrne, K. J.
    Blayney, J. K.
    Kerr, K. M.
    Sheaff, M.
    Richard, D. J.
    Hamilton, P. W.
    James, J.
    Quinn, J. E.
    Fennell, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
    Jianlin Liu
    Ragini Adhav
    Kai Miao
    Sek Man Su
    Lihua Mo
    Un In Chan
    Xin Zhang
    Jun Xu
    Jianjie Li
    Xiaodong Shu
    Jianming Zeng
    Xu Zhang
    Xueying Lyu
    Lakhansing Pardeshi
    Kaeling Tan
    Heng Sun
    Koon Ho Wong
    Chuxia Deng
    Xiaoling Xu
    Nature Communications, 11
  • [36] AMH paracrine signaling between cancer and mesothelial cells modulates the ovarian tumor immune microenvironment
    Chauvin, Maeva Y.
    CANCER RESEARCH, 2024, 84 (05)
  • [37] PARP INHIBITION INDUCES BAX/BAK INDEPENDENT SYNTHETIC LETHALITY OF BRCA1-DEFICIENT NON-SMALL CELL LUNG CANCER
    Paul, Ian
    Savage, Kienan I.
    Blainey, Jaine
    Lamers, Elisabeth
    Gately, Kathy
    Kerr, Keith M.
    Sheaff, Michael
    Richard, Derek J.
    Hamilton, Peter
    James, Jackie
    O'Byrne, Kenneth J.
    Harkin, Paul
    Quinn, Jennifer E.
    Fennell, Dean A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S423 - S424
  • [38] The Multifactorial Role of PARP-1 in Tumor Microenvironment
    Manuel Marti, Juan
    Fernandez-Cortes, Monica
    Serrano-Saenz, Santiago
    Zamudio-Martinez, Esteban
    Delgado-Bellido, Daniel
    Garcia-Diaz, Angel
    Javier Oliver, Francisco
    CANCERS, 2020, 12 (03)
  • [39] PD-1 modulates immune cell functions in prostate tumor microenvironment
    Mishra, M.
    Singh, R.
    Manne, U.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1755 - 1756
  • [40] Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
    Henneman, Linda
    van Miltenburg, Martine H.
    Michalak, Ewa M.
    Braumuller, Tanya M.
    Jaspers, Janneke E.
    Drenth, Anne Paulien
    de Korte-Grimmerink, Renske
    Gogola, Ewa
    Szuhai, Karoly
    Schlicker, Andreas
    Bin Ali, Rahmen
    Pritchard, Colin
    Huijbers, Ivo J.
    Berns, Anton
    Rottenberg, Sven
    Jonkers, Jos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (27) : 8409 - 8414
12345